MPs, experts & families affected by Friedreich's Ataxia (FA) have called on the government to enable interim access to Omaveloxolone - the first licensed treatment for the rare neurodegenerative disease & the only one shown to slow its progression.
uclhospitals.brc.nihr.ac.uk/news/calls-act…
uclhospitals.brc.nihr.ac.uk/news/calls-act…